Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
Status:
Not yet recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The goal of this prospective phase 2 study is to assess the efficacy and safety of intestinal
or multivisceral transplantation for participants with PMP not amenable to other
curative-intent treatments. Participants will undergo intestinal/multivisceral
transplantation. Participants will be followed for 12 months to assess efficacy and safety.